Natural history of HFE simple heterozygosity for C282Y and H63D: A prospective 12-year study

Journal of Gastroenterology and Hepatology (Australia)

Volumn 30, Issue 4, 2015, Pages 719-725

  Zaloumis, Sophie G ^a   Allen, Katrina J ^b,c,d   Bertalli, Nadine A ^b   Turkovic, Lidija ^a   Delatycki, Martin B ^b,c,g   Nicoll, Amanda J ^e   Mclaren, Christine E ^l   English, Dallas R ^a,f   Hopper, John L ^a   Giles, Graham G ^a,f   Anderson, Gregory J ^h   Olynyk, John K ^j,k   Powell, Lawrie W ^h,i   Gurrin, Lyle C ^a   Bahlo, Melanie ^m   Vulpe, Chris D ⁿ   Forrest, Sue M ^o   Fletcher, Ashley R ^f  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d ROYAL CHILDREN'S HOSPITAL   (Australia)

^e ROYAL MELBOURNE HOSPITAL   (Australia)

^f CANCER EPIDEMIOLOGY CENTRE   (Australia)

^g AUSTIN HEALTH   (Australia)

^h QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

ⁱ ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^j FREMANTLE HOSPITAL   (Australia)

^k UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^l UNIVERSITY OF CALIFORNIA   (United States)

^m WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

ⁿ UNIVERSITY OF CALIFORNIA   (United States)

^o Australian Genome Research Facility Ltd   (Australia)

more..

Author keywords

Hereditary disease; Iron overload related disease; Liver disease; Serum ferritin; Transferrin saturation

Indexed keywords

C282Y PROTEIN; H63D PROTEIN; HFE PROTEIN; PROTEIN; TRANSFERRIN; UNCLASSIFIED DRUG; HFE PROTEIN, HUMAN; HLA ANTIGEN CLASS 1; MEMBRANE PROTEIN;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTHRITIS; ARTICLE; BLOOD DONOR; CONTROLLED STUDY; DISEASE ASSOCIATION; FATIGUE; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; GENE MUTATION; HEMOCHROMATOSIS; HEREDITARY HEMOCHROMATOSIS; HETEROZYGOTE; HISTORY; HOMOZYGOTE; HUMAN; IRON OVERLOAD; MAJOR CLINICAL STUDY; MALE; NORTHERN EUROPEAN; PHLEBOTOMY; POSTMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; COHORT ANALYSIS; GENETICS; GENOTYPE; MIDDLE AGED; MORBIDITY; TIME;

ADULT; AGED; COHORT STUDIES; FEMALE; GENOTYPE; HEMOCHROMATOSIS; HETEROZYGOTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IRON OVERLOAD; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MORBIDITY; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 84924787477     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12804     Document Type: Article

References (17)

1. Pietrangelo A. Hereditary hemochromatosis-a new look at an old disease. N. Engl. J. Med. 2004; 350: 2383-2397.
2. Feder JN, Gnirke A, Thomas W etal. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat. Genet. 1996; 13: 399-408.
3. Bacon BR, Olynyk JK, Brunt EM, Britton RS, Wolff RK. HFE genotype in patients with hemochromatosis and other liver diseases. Ann. Intern. Med. 1999; 130: 953-962.
4. Adams P, Brissot P, Powell LW. EASL International Consensus Conference on haemochromatosis. J. Hepatol. 2000; 33: 485-504.
5. Allen KJ, Gurrin LC, Constantine CC etal. Iron-overload-related disease in HFE hereditary hemochromatosis. N. Engl. J. Med. 2008; 358: 221-230.
6. Gurrin LC, Bertalli NA, Dalton GW etal. HFE C282Y/H63D compound heterozygotes are at low risk of hemochromatosis-related morbidity. Hepatology 2009; 50: 94-101.
7. Adams PC, Reboussin DM, Barton JC etal. Hemochromatosis and iron-overload screening in a racially diverse population. N. Engl. J. Med. 2005; 352: 1769-1778.
8. Girouard J, Giguere Y, Delage R, Rousseau F. Prevalence of HFE gene C282Y and H63D mutations in a French-Canadian population of neonates and in referred patients. Hum. Mol. Genet. 2002; 11: 185-189.
9. Gochee PA, Powell LW, Cullen DJ, Du Sart D, Rossi E, Olynyk JK. A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation. Gastroenterology 2002; 122: 646-651.
10. Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW. A population-based study of the clinical expression of the hemochromatosis gene. N. Engl. J. Med. 1999; 341: 718-724.
11. Rossi E, Olynyk JK, Cullen DJ etal. Compound heterozygous hemochromatosis genotype predicts increased iron and erythrocyte indices in women. Clin. Chem. 2000; 46: 162-166.
12. Acton RT, Barton JC, Passmore LV etal. Relationships of serum ferritin, transferrin saturation, and HFE mutations and self-reported diabetes in the Hemochromatosis and Iron Overload Screening (HEIRS) study. Diabetes Care 2006; 29: 2084-2089.
13. Delatycki MB, Allen KJ, Nisselle AE etal. Use of community genetic screening to prevent HFE-associated hereditary haemochromatosis. Lancet 2005; 366: 314-316.
14. Giles GG, English DR. The Melbourne Collaborative Cohort Study. IARC Sci. Publ. 2002; 156: 69-70.
15. Gurrin LC, Osborne NJ, Constantine CC etal. The natural history of serum iron indices for HFE C282Y homozygosity associated with hereditary hemochromatosis. Gastroenterology 2008; 135: 1945-1952.
16. Olynyk JK, Gan E, Tan T. Predicting iron overload in hyperferritinemia. Clin. Gastroenterol. Hepatol. 2009; 7: 359-362.
17. Bertalli NA, Allen KJ, McLaren CE etal. A comparison of self-reported and record-linked blood donation history in an Australian cohort. Transfusion 2011; 51: 2189-2198.